New research has highlighted a “significant association” between low Toe Brachial Index (TBI) and the presence of coronary artery disease (CAD) in diabetic foot syndrome patients, suggesting TBI could...
A new drug delivery system can cut the dosing schedule for semaglutide to just once a month, according to new research presented last week at EASD 2024. Lead author Dr Claire Mégret, from ADOCIA, sai...
The results from clinical trials evaluating once weekly insulin efsitora alfa in adults with type 2 diabetes using basal insulin for the first time have been released. Eli Lilly and Company has also p...
Researchers have published the first study to document the sausage toe as a prevalent presentation of diabetic toe infection. The study set out to document the prevalence, presentation, treatment moda...
Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported. Study participants taki...
Nine “significant” risk factors for lower extremity amputation in diabetic foot ulcer patients have been identified in new research. The meta-analysis of 16 studies taken from Chinese and English data...
Two features of an innovative hybrid closed loop system can help people improve their glucose management at all times of the day, new research has revealed. The boost and ease-off features in CamAPS F...
Using vLPM and vCPM allografts in the treatment of diabetic lower extremity ulcers is linked to improved outcomes when compared to using other cellular tissue products or standard of care, a study has...
Healthcare professionals are invited to join an online event aimed at discussing hybrid closed loop therapy options for pregnant women with type 1 diabetes. Hosted by the NHS Diabetes Programme and CD...